Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05115305 · ClinicalTrials.gov registry record
Prodigy, a Level 2 Sleep Study Device, Validation Study
A clinical trial of Sleep Apnea, sponsored by Cerebra Medical.
- Completed
- Registry status
- 84
- Enrollment target
- 2
- Study locations
NCT05115305: Completed study of Sleep Apnea, sponsored by Cerebra Medical.
NCT05115305 is a study of Sleep Apnea that has completed, run by Cerebra Medical. The registered enrollment target is 84 participants, below the 2,987-participant average among 36 other Sleep Apnea trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05115305, a study of Sleep Apnea, has completed, sponsored by Cerebra Medical.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
- 2
- Study locations
Study Summary
The Prodigy system, developed by Cerebra Medical Ltd, allows for the generation of the same information in the home that is currently only obtained in in-laboratory studies. The objective of the current study is to demonstrate that the signals obtained by this comprehensive, portable system are comparable to those obtained in in-laboratory studies.
Primary Outcome
To compare Level 1 and Level 2 sleep tests on TST
Conditions Studied
Study Locations (2)
New York
- St Charles Sleep Disorders Center - Port Jefferson
Ontario
- Hamilton Sleep Disorders Clinic - Hamilton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2022-01-14 |
| Est. Completion | 2022-04-09 |
What the finished NCT05115305 record still lists
NCT05115305 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 2,987-participant average among 36 other Sleep Apnea trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Sleep Apnea appearing as the primary indexed condition, and to 0 interventions.
NCT05115305 reports a single indexed study location in New York, Ontario.
Frequently Asked Questions
What is clinical trial NCT05115305 about?
NCT05115305 is a clinical study titled "Prodigy, a Level 2 Sleep Study Device, Validation Study". The Prodigy system, developed by Cerebra Medical Ltd, allows for the generation of the same information in the home that is currently only obtained in in-laboratory studies. The objective of the current study is to demonstrate that the signals obtained by this comprehensive, portable system are com...
What is the current status of trial NCT05115305?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2022-01-14. Estimated completion is 2022-04-09.
What conditions does trial NCT05115305 study?
This clinical trial studies the following conditions: Sleep Apnea.
Who is sponsoring clinical trial NCT05115305?
This trial is sponsored by Cerebra Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05115305 being conducted?
This trial has 2 study locations across New York, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05115305's enrollment target sits among peer trials
84 21st of 36 higher than 16 of 36 other Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Research Framework Exploring Sleep Health
RECRUITING
-
Mechanisms of Prediabetic States in Sleep Apnea
RECRUITING · NA
-
Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study
RECRUITING · Phase 4
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
Sleep Apnea in Elderly
RECRUITING · Phase 4
-
Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI